See more : Clover Leaf Capital Corp. (CLOE) Income Statement Analysis – Financial Results
Complete financial analysis of Link Reservations Inc. (LRSV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Link Reservations Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- EVRAZ plc (EVRZF) Income Statement Analysis – Financial Results
- Sanco Trans Limited (SANCTRN.BO) Income Statement Analysis – Financial Results
- Sumitomo Precision Products Co., Ltd. (6355.T) Income Statement Analysis – Financial Results
- Diverger Limited (DVR.AX) Income Statement Analysis – Financial Results
- JASON (4570.TWO) Income Statement Analysis – Financial Results
Link Reservations Inc. (LRSV)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.linkreservationsinc.com
About Link Reservations Inc.
Link Reservations Inc. develops and markets medicinal mushroom and cannabidiol wellness products for humans and pets in Europe and the United States. It offers hemp-based CBD products for cats, dogs, and horses, as well as for humans. The company was formerly known as Vendum Batteries, Inc. and changed its name to Link Reservations Inc. in May 2015. Link Reservations Inc. was incorporated in 2006 and is based in Kington, the United Kingdom.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 18.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 18.06K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 523.71K | 328.53K | 26.96K | 37.40K | 25.90K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | -223.35K | 0.00 | 237.82K | 94.46K | 19.44K | 20.19K | 24.57K | 36.94K | 523.71K | 328.53K | 26.96K | 37.40K | 25.90K |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -505.41K | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | -223.35K | 0.00 | 237.82K | 94.46K | 19.44K | 20.19K | 24.57K | 36.94K | 523.71K | 328.53K | 27.61K | 51.00K | 26.28K |
Cost & Expenses | -223.35K | 0.00 | 237.82K | 94.46K | 19.44K | 20.19K | 24.57K | 36.94K | 523.71K | 328.53K | 27.61K | 51.00K | 26.28K |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 11.86K | 0.00 | 1.62K | 1.62K | 0.00 | 0.00 | 101.73K | 6.84K | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 386.00 | 386.00 | 385.00 |
EBITDA | 5.13K | 136.23K | -219.76K | -95.24K | -19.44K | -4.50K | -24.57K | -36.94K | -677.80K | -628.53K | -27.22K | -50.62K | -25.90K |
EBITDA Ratio | 0.00% | 0.00% | -1,216.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -223.35K | 0.00 | -219.76K | -94.46K | -19.44K | -20.19K | -24.57K | -36.94K | -523.71K | -328.53K | -27.61K | -51.00K | -26.28K |
Operating Income Ratio | 0.00% | 0.00% | -1,216.97% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 212.90K | 0.00 | -11.86K | -779.00 | -1.62K | 14.07K | 0.00 | -2.00 | -255.81K | -306.84K | 0.00 | 0.00 | 0.00 |
Income Before Tax | -10.45K | 0.00 | -231.62K | -95.24K | -21.06K | -6.12K | -24.57K | -36.94K | -779.52K | -635.38K | 0.00 | 0.00 | 0.00 |
Income Before Tax Ratio | 0.00% | 0.00% | -1,282.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | -223.35K | 0.00 | -206.30K | -171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income | -10.45K | 0.00 | -231.62K | -95.24K | -21.06K | -6.12K | -24.57K | -36.94K | -779.52K | -635.38K | -27.61K | -51.00K | -26.28K |
Net Income Ratio | 0.00% | 0.00% | -1,282.64% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Weighted Avg Shares Out | 790.10M | 0.00 | 375.50M | 220.10M | 220.10M | 205.09M | 175.09M | 1.32B | 504.71M | 332.96M | 1.10B | 1.10B | 1.04B |
Weighted Avg Shares Out (Dil) | 790.10M | 0.00 | 375.50M | 220.10M | 220.10M | 205.09M | 175.09M | 1.32B | 504.71M | 332.96M | 1.10B | 1.10B | 1.04B |
Link Reservations Inc/LinkResPet (LRSV) Expands Retail Presence in Florida as Products Now Stocked in All 4 Collins Tobacco & Vape Shops
Link Reservations Inc/LinkResPet (LRSV) Grows Retail Presence as Company Identifies New Stockist in Florida-based Collins Tobacco & Vape Retail Store
Link Reservations Inc./LinkResPet (LRSV) to start accepting Bitcoin/Crypto payments
Link Reservations Inc./LinkResPet (LRSV) to Start Selling CBD Products on Amazon US
Link Reservations Inc/LinkResPet (LRSV) Boosts Selling Activities through new SupplierGATEWAY presence
Link Reservations Inc./LinkResPet (LRSV) Boosts Selling Activities Through New SupplierGATEWAY Presence
Link Reservations Inc/LinkResPet (LRSV) CBD Product For Dogs Now Back In Stock Following Biggest Sales Quarter Yet
Link Reservations Inc./LinkResPet (LRSV) CBD Product for Dogs Now Back in Stock Following Biggest Sales Quarter Yet
Link Reservations Inc/LinkResPet (LRSV) Ensures Strong Quality Control and Testing for Pet Hemp Oil Extract
Link Reservations Inc./LinkResPet (LRSV) Developing CBD Product To Combat Pet Obesity
Source: https://incomestatements.info
Category: Stock Reports